Southborough, United States
Veristat, founded in 1994, is a United States-based leader in the Life Sciences and Pharmaceutical industries. This full-service contract research organization (CRO) and consultancy primarily focuses on drug and biologic development, integrating strategic planning, regulatory expertise, and clinical trial execution.
The company's core competence lies in its ability to advance complex and novel therapies through collaborative partnerships with clients, ensuring the rapid delivery of life-changing treatments. With a remarkable 30-year track record, Veristat targets challenging therapeutic areas like rare cancers, CNS/Neurological disorders, Endocrine/metabolic disorders, and infectious diseases.
Despite being alert to recent fraudulent attempts falsely using its name, Veristat maintains its focus on bold scientific innovation, underpinned by a versatile approach. Note that there is no recent investment data or identified investors for the company at this time, making it ripe for potential investor engagement.
